Targeting virus–glycan recognition in influenza viruses and coronaviruses: from the molecular principles to glycomimetic antivirals strategies
- 1aCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain.
- 2aCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain.bIkerbasque, Basque Foundation for Science, Bilbao, Spain.
Abstract
Glycans constitute the first molecular landscape encountered by viruses during infection and play fundamental roles in viral attachment, host adaptation, tissue tropism, and immune evasion. Far from being passive components of the cell surface, host glycans actively regulate virus–host interactions by functioning as attachment factors, entry receptors, or modulators of receptor engagement, while viral glycans contribute to immune escape and infectivity. Consequently, the molecular recognition of glycans has emerged as a major determinant of viral evolution and pathogenicity. This review presents our perspective on the structural and mechanistic principles that govern virus–glycan recognition, focusing on influenza viruses and coronaviruses as paradigmatic examples. We discuss how subtle variations in glycan structure, including glycosidic linkage, chain length, multivalent presentation, and chemical modifications such as O-acetylation, shape viral receptor specificity, host range, and cross-species transmission. Recent advances from structural biology, NMR spectroscopy, glycan arrays, computational modeling, and glycochemistry have substantially expanded our understanding of these dynamic recognition events and their evolutionary consequences. We further highlight how these insights are driving the development of glycomimetic antivirals designed to interfere with the earliest stages of infection. Approaches based on multivalent sialoglycan analogues, stabilized carbohydrate mimetics, and heparan sulfate-inspired scaffolds illustrate the growing potential of targeting glycan-mediated recognition as an alternative or complementary antiviral strategy. By integrating molecular recognition, viral adaptation, and medicinal chemistry, this review underscores the opportunities offered by glycobiology to develop innovative, potentially broad-spectrum antiviral therapeutics.
Related
- High-Entropy Alloys as Materials for Solid-State Hydrogen Storage: From Fundamental Principles to Directed Design Strategies
- Learning Multiscale Computational Strategies for Supramolecular Recognition
- Probing VOC Capture and Sensing in BN-Engineered Quasi-2D FullereneMonolayers: First-Principles Insights
- From β-AlF3 to Amorphous Aluminium Chlorofluoride (ACF) Models: A First-Principles Study
- Engineering optoelectronic and excitonic properties in carbon quantum dots via defect encoding: a first-principles study
BibTeX
@article{fernandezperez2026targeting,
title = {{Targeting virus–glycan recognition in influenza viruses and coronaviruses: from the molecular principles to glycomimetic antivirals strategies}},
author = {Cristina Fernández-Pérez and María Emilia Cuervo and Iris A. Bermejo and Jon Imanol Quintana and Ana Gimeno and Ana Ardá and Jesús Jiménez-Barbero and Luca Unione},
journal = {RSC Chemical Biology},
year = {2026},
month = sep,
doi = {10.1039/d6cb00215c},
url = {https://doi.org/10.1039/d6cb00215c},
note = {CC BY-NC 3.0},
}
RIS
TY - JOUR
TI - Targeting virus–glycan recognition in influenza viruses and coronaviruses: from the molecular principles to glycomimetic antivirals strategies
AU - Cristina Fernández-Pérez
AU - María Emilia Cuervo
AU - Iris A. Bermejo
AU - Jon Imanol Quintana
AU - Ana Gimeno
AU - Ana Ardá
AU - Jesús Jiménez-Barbero
AU - Luca Unione
PY - 2026
DA - 2026/09/01
JO - RSC Chemical Biology
DO - 10.1039/d6cb00215c
UR - https://doi.org/10.1039/d6cb00215c
AB - Glycans constitute the first molecular landscape encountered by viruses during infection and play fundamental roles in viral attachment, host adaptation, tissue tropism, and immune evasion. Far from being passive components of the cell surface, host glycans actively regulate virus–host interactions by functioning as attachment factors, entry receptors, or modulators of receptor engagement, while viral glycans contribute to immune escape and infectivity. Consequently, the molecular recognition of glycans has emerged as a major determinant of viral evolution and pathogenicity. This review presents our perspective on the structural and mechanistic principles that govern virus–glycan recognition, focusing on influenza viruses and coronaviruses as paradigmatic examples. We discuss how subtle variations in glycan structure, including glycosidic linkage, chain length, multivalent presentation, and chemical modifications such as O-acetylation, shape viral receptor specificity, host range, and cross-species transmission. Recent advances from structural biology, NMR spectroscopy, glycan arrays, computational modeling, and glycochemistry have substantially expanded our understanding of these dynamic recognition events and their evolutionary consequences. We further highlight how these insights are driving the development of glycomimetic antivirals designed to interfere with the earliest stages of infection. Approaches based on multivalent sialoglycan analogues, stabilized carbohydrate mimetics, and heparan sulfate-inspired scaffolds illustrate the growing potential of targeting glycan-mediated recognition as an alternative or complementary antiviral strategy. By integrating molecular recognition, viral adaptation, and medicinal chemistry, this review underscores the opportunities offered by glycobiology to develop innovative, potentially broad-spectrum antiviral therapeutics.
SN - 2633-0679
ER -